Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Nuvoli

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Pharmacokinetics|March 11, 2009
Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic functionAlessandra Felici, Susanna Di Segni, Michele Milella, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2024
DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigationBarbara Nuvoli, Andrea Sacconi, Grazia Bottillo, et al.
Oncogene|January 10, 2018
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretomeSimona di Martino, Carla Azzurra Amoreo, Barbara Nuvoli, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Pharmacokinetics|March 11, 2009
Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic functionAlessandra Felici, Susanna Di Segni, Michele Milella, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2024
DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigationBarbara Nuvoli, Andrea Sacconi, Grazia Bottillo, et al.
Oncogene|January 10, 2018
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretomeSimona di Martino, Carla Azzurra Amoreo, Barbara Nuvoli, et al.
Pageof 2